Royal Bank of Canada’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $269M | Buy |
694,935
+199,552
| +40% | +$74M | 0.04% | 376 |
|
|
2026
Q1 | $145M | Buy |
495,383
+38,283
| +8% | +$12.6M | 0.03% | 510 |
|
|
2025
Q4 | $160M | Sell |
457,100
-28,115
| -6% | -$9.5M | 0.03% | 490 |
|
|
2025
Q3 | $157M | Sell |
485,215
-100,065
| -17% | -$31.1M | 0.03% | 509 |
|
|
2025
Q2 | $228M | Sell |
585,280
-134,742
| -19% | -$54.2M | 0.04% | 361 |
|
|
2025
Q1 | $313M | Sell |
720,022
-2,867
| -0.4% | -$1.15M | 0.07% | 260 |
|
|
2024
Q4 | $267M | Buy |
722,889
+29,782
| +4% | +$12.5M | 0.05% | 292 |
|
|
2024
Q3 | $360M | Buy |
693,107
+70,700
| +11% | +$37.8M | 0.07% | 243 |
|
|
2024
Q2 | $337M | Buy |
622,407
+10,431
| +2% | +$5.51M | 0.08% | 240 |
|
|
2024
Q1 | $317M | Sell |
611,976
-79,710
| -12% | -$39.6M | 0.07% | 250 |
|
|
2023
Q4 | $326M | Buy |
691,686
+80,329
| +13% | +$37.1M | 0.08% | 234 |
|
|
2023
Q3 | $266M | Sell |
611,357
-138,368
| -18% | -$62.8M | 0.07% | 246 |
|
|
2023
Q2 | $333M | Buy |
749,725
+122,778
| +20% | +$56.6M | 0.09% | 209 |
|
|
2023
Q1 | $288M | Sell |
626,947
-385,467
| -38% | -$183M | 0.08% | 217 |
|
|
2022
Q4 | $519M | Buy |
1,012,414
+54,435
| +6% | +$27.6M | 0.15% | 137 |
|
|
2022
Q3 | $435M | Buy |
957,979
+26,638
| +3% | +$12.7M | 0.14% | 143 |
|
|
2022
Q2 | $449M | Buy |
931,341
+65,390
| +8% | +$32.3M | 0.13% | 152 |
|
|
2022
Q1 | $425M | Sell |
865,951
-41,546
| -5% | -$19M | 0.11% | 177 |
|
|
2021
Q4 | $421M | Buy |
907,497
+5,866
| +0.7% | +$2.47M | 0.1% | 184 |
|
|
2021
Q3 | $336M | Buy |
901,631
+69,068
| +8% | +$26.2M | 0.09% | 201 |
|
|
2021
Q2 | $318M | Sell |
832,563
-96,783
| -10% | -$37M | 0.08% | 215 |
|
|
2021
Q1 | $334M | Buy |
929,346
+153,248
| +20% | +$49.3M | 0.1% | 188 |
|
|
2020
Q4 | $249M | Sell |
776,098
-44,207
| -5% | -$13.6M | 0.07% | 240 |
|
|
2020
Q3 | $220M | Sell |
820,305
-118,274
| -13% | -$31.8M | 0.08% | 220 |
|
|
2020
Q2 | $247M | Sell |
938,579
-253,108
| -21% | -$67.5M | 0.1% | 185 |
|
|
2020
Q1 | $271M | Buy |
1,191,687
+354,768
| +42% | +$96.7M | 0.13% | 153 |
|
|
2019
Q4 | $253M | Buy |
836,919
+362,063
| +76% | +$99.6M | 0.09% | 202 |
|
|
2019
Q3 | $114M | Sell |
474,856
-201,818
| -30% | -$55.3M | 0.05% | 337 |
|
|
2019
Q2 | $191M | Sell |
676,674
-389,130
| -37% | -$106M | 0.08% | 224 |
|
|
2019
Q1 | $306M | Buy |
1,065,804
+123,876
| +13% | +$35.8M | 0.13% | 152 |
|
|
2018
Q4 | $247M | Sell |
941,928
-13,857
| -1% | -$3.81M | 0.12% | 162 |
|
|
2018
Q3 | $264M | Buy |
955,785
+116,713
| +14% | +$30.3M | 0.11% | 158 |
|
|
2018
Q2 | $200M | Sell |
839,072
-163,637
| -16% | -$37.9M | 0.09% | 196 |
|
|
2018
Q1 | $220M | Buy |
1,002,709
+271,414
| +37% | +$63.8M | 0.1% | 171 |
|
|
2017
Q4 | $165M | Buy |
731,295
+315,036
| +76% | +$67.1M | 0.07% | 232 |
|
|
2017
Q3 | $79M | Sell |
416,259
-3,461
| -0.8% | -$659K | 0.04% | 379 |
|
|
2017
Q2 | $79M | Buy |
419,720
+129,912
| +45% | +$23.3M | 0.04% | 364 |
|
|
2017
Q1 | $47.9M | Buy |
289,808
+119,032
| +70% | +$18.9M | 0.03% | 531 |
|
|
2016
Q4 | $24.6M | Sell |
170,776
-394,561
| -70% | -$52.8M | 0.01% | 920 |
|
|
2016
Q3 | $70.8M | Buy |
565,337
+218,074
| +63% | +$28.2M | 0.04% | 371 |
|
|
2016
Q2 | $45.6M | Buy |
347,263
+31,111
| +10% | +$4.26M | 0.03% | 517 |
|
|
2016
Q1 | $43.9M | Sell |
316,152
-387,964
| -55% | -$51.8M | 0.03% | 508 |
|
|
2015
Q4 | $98.2M | Sell |
704,116
-117,581
| -14% | -$16.2M | 0.06% | 239 |
|
|
2015
Q3 | $115M | Sell |
821,697
-438,290
| -35% | -$65.9M | 0.09% | 167 |
|
|
2015
Q2 | $207M | Buy |
1,259,987
+114,736
| +10% | +$18.3M | 0.14% | 110 |
|
|
2015
Q1 | $177M | Sell |
1,145,251
-117,258
| -9% | -$16.7M | 0.12% | 126 |
|
|
2014
Q4 | $159M | Sell |
1,262,509
-179,875
| -12% | -$22.2M | 0.1% | 142 |
|
|
2014
Q3 | $173M | Sell |
1,442,384
-91,752
| -6% | -$10.5M | 0.12% | 128 |
|
|
2014
Q2 | $165M | Buy |
1,534,136
+482,867
| +46% | +$49.8M | 0.11% | 134 |
|
|
2014
Q1 | $105M | Buy |
1,051,269
+315,280
| +43% | +$28.5M | 0.08% | 183 |
|
|
2013
Q4 | $68M | Buy |
735,989
+254,015
| +53% | +$22.6M | 0.05% | 293 |
|
|
2013
Q3 | $40.3M | Sell |
481,974
-4,614
| -0.9% | -$395K | 0.03% | 423 |
|
|
2013
Q2 | $39.8M | Buy |
+486,588
| New | +$36.4M | 0.03% | 401 |
|
Other funds holding ELV
Royal Bank of Canada's ELV Position: Q2 2026 in Review
Royal Bank of Canada increased its Elevance Health (ELV) stake by 40% in Q2 2026, buying an estimated $74M and bringing the position to 694,935 shares worth $269M. The position accounts for 0.04% of the portfolio, ranked #376.
Royal Bank of Canada first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $519M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Royal Bank of Canada held 694,935 shares of Elevance Health worth $269M as of Q2 2026.
- Royal Bank of Canada bought 199,552 Elevance Health shares in Q2 2026, an estimated $74M.
- Elevance Health made up 0.04% of Royal Bank of Canada's portfolio in Q2 2026, its #376 holding.
- Royal Bank of Canada first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Elevance Health position peaked at $519M in Q4 2022.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.